UCB (EBR:UCB) UCB Media Room: Transparency notification

Directive transparence : information réglementée

13/01/2020 20:10
https://mb.cision.com/Public/18595/3007892/af45481f69fefbd4_800x800ar.jpg ** Transparency notification BlackRock, Inc. ------------------------------------------------------------ =C2=B7 Notification referring to situation on 7 January 2020 =C2=B7 Threshold crossed: 5% =C2=B7 Latest holding: 5.18%=C2=A0 Brussels (Belgium), 13 January 2020 =E2=80=93 20:00 (CET) =E2=80=93 regulat= ed information 1.=C2=A0 Summary of the notification Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large = shareholdings, UCB SA/NV announces that it has received a transparency noti= fication from BlackRock, Inc. (having its registered office at 55 East 52nd= Street, New York, NY, 10055, U.S.A.), dated 8 January 2020. BlackRock, Inc., has notified that, following an acquisition of UCB shares = with voting rights by its affiliates, its holding of UCB shares with voting= rights has increased and has crossed the 5% threshold on 7 January 2020.= =C2=A0 On 7 January 2020, BlackRock, Inc. (taking into account the holding of its = affiliates) Inc. owned=C2=A09 927 826 UCB shares with voting rights (versus= 9 647 211 shares in its previous notification), representing 5.10% of the = total number of shares issued by the company (194 505 658) (versus 4.96% in= its previous notification), as well as 153 082 equivalent financial instru= ments (versus 150 268 in its previous notification) representing 0.08% of t= he total number of shares issued by the company (same % as in its previous = notification).=C2=A0 2.=C2=A0=C2=A0 =C2=A0Content of the notification =C2=B7 Reason for the notification: Acquisition or disposal of voting secur= ities or voting rights.=C2=A0 =C2=B7 Notification by: A parent undertaking or a controlling person. =C2=B7 Persons subject to the notification requirement:=C2=A0 =C2=A0https://mb.cision.com/Public/18595/3007892/ac73b921d3780ee9_800x800ar= .jpg =C2=B7 Date on which the threshold is crossed: 7 January 2020. =C2=B7 Threshold crossed (in %): 5% =C2=B7 Denominator: 194 505 658. =C2=B7 Notified details: =C2=A0https://mb.cision.com/Public/18595/3007892/a821fa78f210c54d_800x800ar= .jpg https://mb.cision.com/Public/18595/3007892/b0b1d43f6bcce21c_800x800ar.jpg =C2=B7 Chain of controlled undertakings through which the holding is effect= ively held: Please see the full chain of control in the =E2=80=98Chain of Control=E2=80= =99 tab. =C2=B7 Additional information:=C2=A0 The disclosure obligation arose due to voting rights attached to shares for= BlackRock, Inc. going above 5%.=C2=A0 3.=C2=A0 Further information=C2=A0 This press release and the detailed transparency notification are available= on UCB SA/NV=E2=80=99s website via the following link (https://www.ucb.com= /investors/UCB-shareholders) . An updated overview of the UCB SA/NV large shareholdings will be available = on UCB SA/NV=E2=80=99s website via the following link (https://www.ucb.com/= investors/UCB-shareholders) . Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, =C2=A0Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0 =C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With 7 500 people in approxima= tely 40 countries, the company generated revenue of =E2=82=AC 4.6 billion i= n 2018. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit= ter: @UCB_news =C2=A0 Image Capture 1 Transparency Notification Jan 13 2020 (https://mb.cision.com/Publ= ic/18595/3007892/ac73b921d3780ee9_org.jpg) Image Capture 2 Transparency Notification Jan 13 2020 (https://mb.cision.com/Publ= ic/18595/3007892/a821fa78f210c54d_org.jpg) Image Capture 3 Transparency Notification Jan 13 2020 (https://mb.cision.com/Publ= ic/18595/3007892/b0b1d43f6bcce21c_org.jpg)=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x33309x1x6868579x24000= x6&Email=3Dregnews%40symexglobal.com.=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=

26/06/2020 20:00
19/06/2020 20:00
16/06/2020 07:01
12/06/2020 21:00
11/06/2020 20:00
05/06/2020 07:00
04/06/2020 07:00
02/06/2020 20:00
22/05/2020 20:00
13/05/2020 20:00